| The 2023 report of the Lancet Countdown on health and climate change: the imperative for a health-centred response in a world facing irreversible harms M Romanello, C Di Napoli, C Green, H Kennard, P Lampard, D Scamman, ... The Lancet 402 (10419), 2346-2394, 2023 | 523 | 2023 |
| Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence M Treskova-Schwarzbach, L Haas, S Reda, A Pilic, A Borodova, K Karimi, ... BMC medicine 19, 1-26, 2021 | 201 | 2021 |
| Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B. 1.617. 2) variant: second interim results of a living systematic review and meta-analysis, 1 … T Harder, W Külper-Schiek, S Reda, M Treskova-Schwarzbach, J Koch, ... Eurosurveillance 26 (41), 2100920, 2021 | 166 | 2021 |
| Beschlussentwurf der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung S Vygen-Bonnet, J Koch, C Bogdan, T Harder, U Heininger, K Kling, ... Robert Koch-Institut, 2021 | 111 | 2021 |
| Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany M Roessler, F Tesch, M Batram, J Jacob, F Loser, O Weidinger, D Wende, ... PLoS medicine 19 (11), e1004122, 2022 | 100 | 2022 |
| The 2024 Europe report of the Lancet Countdown on health and climate change: unprecedented warming demands unprecedented action KR Van Daalen, C Tonne, JC Semenza, J Rocklöv, A Markandya, ... The Lancet Public Health 9 (7), e495-e522, 2024 | 79 | 2024 |
| Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe A Kuhlmann, T Schmidt, M Treskova, J López-Bastida, R Linertova, ... The European Journal of Health Economics 17, 79-87, 2016 | 74 | 2016 |
| Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based … M Treskova, I Aumann, H Golpon, J Vogel-Claussen, T Welte, ... BMC medicine 15, 1-15, 2017 | 60 | 2017 |
| The 2024 report of the Lancet Countdown on health and climate change: facing record-breaking threats from delayed action M Romanello, M Walawender, SC Hsu, A Moskeland, Y Palmeiro-Silva, ... The Lancet 404 (10465), 1847-1896, 2024 | 53 | 2024 |
| Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19 M Roessler, F Tesch, M Batram, J Jacob, F Loser, O Weidinger, D Wende, ... MedRxiv, 2021.10. 21.21265133, 2021 | 53 | 2021 |
| Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review W Külper-Schiek, V Piechotta, A Pilic, M Batke, LS Dreveton, B Geurts, ... Frontiers in immunology 13, 940562, 2022 | 46 | 2022 |
| Determinants of RSV epidemiology following suppression through pandemic contact restrictions M Koltai, F Krauer, D Hodgson, E van Leeuwen, ... Epidemics 40, 100614, 2022 | 34 | 2022 |
| Bevölkerung mit einem erhöhten Risiko für schwere COVID-19-Verläufe in Deutschland. Auswertungen der Studie GEDA 2019/2020-EHIS A Rommel, M Treskova-Schwarzbach, S Scholz, E von der Lippe Robert Koch-Institut, 2021 | 29 | 2021 |
| Cost effectiveness of elderly pneumococcal vaccination in presence of higher-valent pneumococcal conjugate childhood vaccination: systematic literature review with focus on … M Treskova, SM Scholz, A Kuhlmann Pharmacoeconomics 37, 1093-1127, 2019 | 26 | 2019 |
| Decision-support tools to build climate resilience against emerging infectious diseases in Europe and beyond J Rocklöv, JC Semenza, S Dasgupta, EJZ Robinson, A Abd El Wahed, ... The Lancet Regional Health–Europe 32, 2023 | 24 | 2023 |
| Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen M Rößler, J Jacob, L Risch, F Tesch, D Enders, D Wende, R Jucknewitz, ... Robert Koch-Institut, 2021 | 22 | 2021 |
| Analysis of contemporary HIV/AIDS health care costs in Germany: driving factors and distribution across antiretroviral therapy lines M Treskova, A Kuhlmann, J Bogner, M Hower, H Heiken, HJ Stellbrink, ... Medicine 95 (26), e3961, 2016 | 21 | 2016 |
| Einfluss von Impfungen und Kontaktreduktionen auf die dritte Welle der SARS-CoV-2-Pandemie und perspektivische Rückkehr zu prä-pandemischem Kontaktverhalten S Scholz, M Waize, F Weidemann, M Treskova-Schwarzbach, L Haas, ... Robert Koch-Institut, 2021 | 16 | 2021 |
| Analysis of driving factors of willingness to use and willingness to pay for existing pharmacological smoking cessation aids among young and middle-aged adults in Germany I Aumann, M Treskova, N Hagemann, JM von der Schulenburg Applied health economics and health policy 14, 441-452, 2016 | 16 | 2016 |
| Die Impfung gegen COVID-19 in Deutschland zeigt eine hohe Wirksamkeit gegen SARS-CoV-2-Infektionen, Krankheitslast und Sterbefälle M Waize, S Scholz, O Wichmann, T Harder, M Treskova-Schwarzbach, ... Robert Koch-Institut, 2021 | 15 | 2021 |
